$Methanolic fraction from Tamala (Diospyros montana Roxb.) ameliorates anxiety like behaviour via 5-HT2A pathway in rats$
Código QR

Methanolic fraction from Tamala (Diospyros montana Roxb.) ameliorates anxiety like behaviour via 5-HT2A pathway in rats

Background: D. montana (Roxb.) is a medicinal plant cultivated throughout Eastern Asia, comprises several biologically active compounds, such as steroids, naphthoquinones, polyphenols, and flavonoids. Earlier reports revealed that D. montana has been used for anti-inflammatory, antiviral, anticancer...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ankur Kumar Tanwar, Ram Sharma, Sukesh Kumar Gupta
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2022
Materias:	D. montana (Roxb.) Ebenaceae Soxhlation Phytochemical investigation Methanolic extract Anxiety-like behaviour Other systems of medicine RZ201-999
Acceso en línea:	https://doaj.org/article/1c6695f5d7be4225a367584418ff12f6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:1c6695f5d7be4225a367584418ff12f6
record_format	dspace
spelling	oai:doaj.org-article:1c6695f5d7be4225a367584418ff12f62021-11-12T04:49:44ZMethanolic fraction from Tamala (Diospyros montana Roxb.) ameliorates anxiety like behaviour via 5-HT2A pathway in rats2667-031310.1016/j.phyplu.2021.100150https://doaj.org/article/1c6695f5d7be4225a367584418ff12f62022-02-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2667031321001329https://doaj.org/toc/2667-0313Background: D. montana (Roxb.) is a medicinal plant cultivated throughout Eastern Asia, comprises several biologically active compounds, such as steroids, naphthoquinones, polyphenols, and flavonoids. Earlier reports revealed that D. montana has been used for anti-inflammatory, antiviral, anticancer, inhibitor of prostaglandin synthesis, hypolipidemic, and antileukemic agent. However, the anxiolytic activity of D. montana yet not explained. Therefore, the objective of this study is to investigate the anxiolytic effect of the methanolic extract of powder extracted from D. montana (Roxb.) leaves. Method: The anxiolytic activity was evaluated in an open-field test (OFT), hole board test (HBT) and elevated plus maze test (EPM). The rats received an oral pre-treatment of methanolic extract of Diospyros montana (MDM) (50, 100, 200 mg/kg; p.o.) for 7 days and the anxiolytic activity were estimated in experimental rat models. Result: MDM (100 and 200 mg/kg) and diazepam increased behaviour parameters in hole board test in terms of head-dip, a ratio of head-dip/sniffing, and decreased sniffing activity. Further, MDM (100 and 200 mg/kg) and diazepam increased behavioural performance in the EPM and OFT test paradigm. Treatment with MDM (100 and 200 mg/kg) and diazepam increased serotonin level and mRNA expression of the 5-HT2A receptor in the amygdala of experimental rats. In an additional set of experiments, in OFT, HBT and EPM studies, flumazenil attenuated the anxiolytic effect of the minimum effective dose of MDM (100 mg/kg), suggesting the mechanism mediated by the GABAA receptor. Furthermore, MDM-100 mg/kg has shown a lack of sedative-like effect relative to diazepam (6 mg/kg, p.o.) in the OFT and EPM test paradigm. Conclusion: The present findings indicate that anxiolytic effect of MDM may involve GABA and serotonin mediated mechanisms, and MDM can be a potential therapeutic agent for the management of anxiety illustrated in fig-11.Ankur Kumar TanwarRam SharmaSukesh Kumar GuptaElsevierarticleD. montana (Roxb.)EbenaceaeSoxhlationPhytochemical investigationMethanolic extractAnxiety-like behaviourOther systems of medicineRZ201-999ENPhytomedicine Plus, Vol 2, Iss 1, Pp 100150- (2022)
institution	DOAJ
collection	DOAJ
language	EN
topic	D. montana (Roxb.) Ebenaceae Soxhlation Phytochemical investigation Methanolic extract Anxiety-like behaviour Other systems of medicine RZ201-999
spellingShingle	D. montana (Roxb.) Ebenaceae Soxhlation Phytochemical investigation Methanolic extract Anxiety-like behaviour Other systems of medicine RZ201-999 Ankur Kumar Tanwar Ram Sharma Sukesh Kumar Gupta Methanolic fraction from Tamala (Diospyros montana Roxb.) ameliorates anxiety like behaviour via 5-HT2A pathway in rats
description	Background: D. montana (Roxb.) is a medicinal plant cultivated throughout Eastern Asia, comprises several biologically active compounds, such as steroids, naphthoquinones, polyphenols, and flavonoids. Earlier reports revealed that D. montana has been used for anti-inflammatory, antiviral, anticancer, inhibitor of prostaglandin synthesis, hypolipidemic, and antileukemic agent. However, the anxiolytic activity of D. montana yet not explained. Therefore, the objective of this study is to investigate the anxiolytic effect of the methanolic extract of powder extracted from D. montana (Roxb.) leaves. Method: The anxiolytic activity was evaluated in an open-field test (OFT), hole board test (HBT) and elevated plus maze test (EPM). The rats received an oral pre-treatment of methanolic extract of Diospyros montana (MDM) (50, 100, 200 mg/kg; p.o.) for 7 days and the anxiolytic activity were estimated in experimental rat models. Result: MDM (100 and 200 mg/kg) and diazepam increased behaviour parameters in hole board test in terms of head-dip, a ratio of head-dip/sniffing, and decreased sniffing activity. Further, MDM (100 and 200 mg/kg) and diazepam increased behavioural performance in the EPM and OFT test paradigm. Treatment with MDM (100 and 200 mg/kg) and diazepam increased serotonin level and mRNA expression of the 5-HT2A receptor in the amygdala of experimental rats. In an additional set of experiments, in OFT, HBT and EPM studies, flumazenil attenuated the anxiolytic effect of the minimum effective dose of MDM (100 mg/kg), suggesting the mechanism mediated by the GABAA receptor. Furthermore, MDM-100 mg/kg has shown a lack of sedative-like effect relative to diazepam (6 mg/kg, p.o.) in the OFT and EPM test paradigm. Conclusion: The present findings indicate that anxiolytic effect of MDM may involve GABA and serotonin mediated mechanisms, and MDM can be a potential therapeutic agent for the management of anxiety illustrated in fig-11.
format	article
author	Ankur Kumar Tanwar Ram Sharma Sukesh Kumar Gupta
author_facet	Ankur Kumar Tanwar Ram Sharma Sukesh Kumar Gupta
author_sort	Ankur Kumar Tanwar
title	Methanolic fraction from Tamala (Diospyros montana Roxb.) ameliorates anxiety like behaviour via 5-HT2A pathway in rats
title_short	Methanolic fraction from Tamala (Diospyros montana Roxb.) ameliorates anxiety like behaviour via 5-HT2A pathway in rats
title_full	Methanolic fraction from Tamala (Diospyros montana Roxb.) ameliorates anxiety like behaviour via 5-HT2A pathway in rats
title_fullStr	Methanolic fraction from Tamala (Diospyros montana Roxb.) ameliorates anxiety like behaviour via 5-HT2A pathway in rats
title_full_unstemmed	Methanolic fraction from Tamala (Diospyros montana Roxb.) ameliorates anxiety like behaviour via 5-HT2A pathway in rats
title_sort	methanolic fraction from tamala (diospyros montana roxb.) ameliorates anxiety like behaviour via 5-ht2a pathway in rats
publisher	Elsevier
publishDate	2022
url	https://doaj.org/article/1c6695f5d7be4225a367584418ff12f6
work_keys_str_mv	AT ankurkumartanwar methanolicfractionfromtamaladiospyrosmontanaroxbamelioratesanxietylikebehaviourvia5ht2apathwayinrats AT ramsharma methanolicfractionfromtamaladiospyrosmontanaroxbamelioratesanxietylikebehaviourvia5ht2apathwayinrats AT sukeshkumargupta methanolicfractionfromtamaladiospyrosmontanaroxbamelioratesanxietylikebehaviourvia5ht2apathwayinrats
_version_	1718431155719503872

Methanolic fraction from Tamala (Diospyros montana Roxb.) ameliorates anxiety like behaviour via 5-HT2A pathway in rats

Ejemplares similares